Skip to Main Content

Paper Details

Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: a retrospective cohort study.
Prostate Cancer Prostatic Dis
0
2023
Author NameAffiliation
Edward Christopher DeeMemorial Sloan Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2